Plasma Fractionation Market Size, Share & Trends Report

Plasma Fractionation Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts

Market Segmentation

Plasma Fractionation Products Outlook (Revenue, USD Billion, 2018 - 2030)
- Albumin
- Immunoglobulins
  - Intravenous immunoglobulins
  - Subcutaneous immunoglobulins
  - Others
- Coagulation Factors
  - Factor VIII
  - Factor IX
  - VON WILLEBRAND factor
  - Prothrombin complex concentrates
  - Fibrinogen concentrates
  - Others
- Protease inhibitors
- Others
Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
- Centrifugation
- Depth Filtration
- Chromatography
- Others
Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
Plasma Fractionation Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
    - Albumin
    - Immunoglobulins
      - Intravenous immunoglobulins
      - Subcutaneous immunoglobulins
      - Others
    - Coagulation Factors
      - Factor VIII
      - Factor IX
      - VON WILLEBRAND factor
      - Prothrombin complex concentrates
      - Fibrinogen concentrates
      - Others
    - Protease inhibitors
    - Others
  - North America Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
    - Centrifugation
    - Depth Filtration
    - Chromatography
    - Others
  - North America Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
    - Neurology
    - Hematology
    - Oncology
    - Immunology
    - Pulmonology
    - Others
  - North America Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
    - Hospitals & Clinics
    - Clinical Research
    - Others
  - U.S.
    - U.S. Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - U.S. Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - U.S. Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - U.S. Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Canada
    - Canada Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Canada Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Canada Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Canada Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Mexico
    - Mexico Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Mexico Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Mexico Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Mexico Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
- Europe
  - Europe Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
    - Albumin
    - Immunoglobulins
      - Intravenous immunoglobulins
      - Subcutaneous immunoglobulins
      - Others
    - Coagulation Factors
      - Factor VIII
      - Factor IX
      - VON WILLEBRAND factor
      - Prothrombin complex concentrates
      - Fibrinogen concentrates
      - Others
    - Protease inhibitors
    - Others
  - Europe Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
    - Centrifugation
    - Depth Filtration
    - Chromatography
    - Others
  - Europe Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
    - Neurology
    - Hematology
    - Oncology
    - Immunology
    - Pulmonology
    - Others
  - Europe Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
    - Hospitals & Clinics
    - Clinical Research
    - Others
  - U.K.
    - U.K. Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - UK Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - UK Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - UK Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Germany
    - Germany Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Germany Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Germany Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Germany Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - France
    - France Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - France Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - France Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - France Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Italy
    - Italy Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Italy Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Italy Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Italy Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Spain
    - Spain Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Spain Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Spain Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Spain Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Denmark
    - Denmark Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Denmark Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Denmark Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Denmark Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Sweden
    - Sweden Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Sweden Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Sweden Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Sweden Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Norway
    - Norway Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Norway Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Norway Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Norway Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
- Asia Pacific
  - Asia Pacific Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
    - Albumin
    - Immunoglobulins
      - Intravenous immunoglobulins
      - Subcutaneous immunoglobulins
      - Others
    - Coagulation Factors
      - Factor VIII
      - Factor IX
      - VON WILLEBRAND factor
      - Prothrombin complex concentrates
      - Fibrinogen concentrates
      - Others
    - Protease inhibitors
    - Others
  - Asia Pacific Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
    - Centrifugation
    - Depth Filtration
    - Chromatography
    - Others
  - Asia Pacific Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
    - Neurology
    - Hematology
    - Oncology
    - Immunology
    - Pulmonology
    - Others
  - Asia Pacific Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
    - Hospitals & Clinics
    - Clinical Research
    - Others
  - Japan
    - Japan Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Japan Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Japan Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Japan Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - China
    - China Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - China Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - China Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - China Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - India
    - India Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - India Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - India Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - India Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - South Korea
    - South Korea Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - South Korea Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - South Korea Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - South Korea Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Australia
    - Australia Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Australia Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Australia Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Australia Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Thailand
    - Thailand Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Thailand Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Thailand Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Thailand Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
- Latin America
  - Latin America Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
    - Albumin
    - Immunoglobulins
      - Intravenous immunoglobulins
      - Subcutaneous immunoglobulins
      - Others
    - Coagulation Factors
      - Factor VIII
      - Factor IX
      - VON WILLEBRAND factor
      - Prothrombin complex concentrates
      - Fibrinogen concentrates
      - Others
    - Protease inhibitors
    - Others
  - Latin America Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
    - Centrifugation
    - Depth Filtration
    - Chromatography
    - Others
  - Latin America Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
    - Neurology
    - Hematology
    - Oncology
    - Immunology
    - Pulmonology
    - Others
  - Latin America Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
    - Hospitals & Clinics
    - Clinical Research
    - Others
  - Brazil
    - Brazil Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Brazil Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Brazil Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Brazil Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Argentina
    - Argentina Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Argentina Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Argentina Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Argentina Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
- MEA
  - MEA Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
    - Albumin
    - Immunoglobulins
      - Intravenous immunoglobulins
      - Subcutaneous immunoglobulins
      - Others
    - Coagulation Factors
      - Factor VIII
      - Factor IX
      - VON WILLEBRAND factor
      - Prothrombin complex concentrates
      - Fibrinogen concentrates
      - Others
    - Protease inhibitors
    - Others
  - MEA Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
    - Centrifugation
    - Depth Filtration
    - Chromatography
    - Others
  - MEA Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
    - Neurology
    - Hematology
    - Oncology
    - Immunology
    - Pulmonology
    - Others
  - MEA Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
    - Hospitals & Clinics
    - Clinical Research
    - Others
  - South Africa
    - South Africa Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - South Africa Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - South Africa Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - South Africa Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Saudi Arabia
    - Saudi Arabia Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Saudi Arabia Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Saudi Arabia Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Saudi Arabia Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - UAE
    - UAE Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - UAE Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - UAE Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - UAE Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others
  - Kuwait
    - Kuwait Plasma Fractionation Product Outlook (Revenue, USD Billion, 2018 - 2030)
      - Albumin
      - Immunoglobulins
        
        Intravenous immunoglobulins
        
        Subcutaneous immunoglobulins
        
        Others
      - Coagulation Factors
        
        Factor VIII
        
        Factor IX
        
        VON WILLEBRAND factor
        
        Prothrombin complex concentrates
        
        Fibrinogen concentrates
        
        Others
      - Protease inhibitors
      - Others
    - Kuwait Plasma Fractionation Method Outlook (Revenue, USD Billion, 2018 - 2030)
      - Centrifugation
      - Depth Filtration
      - Chromatography
      - Others
    - Kuwait Plasma Fractionation Application Outlook (Revenue, USD Billion, 2018 - 2030)
      - Neurology
      - Hematology
      - Oncology
      - Immunology
      - Pulmonology
      - Others
    - Kuwait Plasma Fractionation End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
      - Hospitals & Clinics
      - Clinical Research
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments